Cover Image
市場調查報告書

Laboratorios LETI S.L.:產品平台分析

Laboratorios LETI S.L. - Product Pipeline Review - 2015

出版商 Global Markets Direct 商品編碼 192675
出版日期 內容資訊 英文 24 Pages
訂單完成後即時交付
價格
Back to Top
Laboratorios LETI S.L.:產品平台分析 Laboratorios LETI S.L. - Product Pipeline Review - 2015
出版日期: 2015年02月28日 內容資訊: 英文 24 Pages
簡介

Laboratorios LETI S.L.ha是專門從事過敏科、皮膚科、免疫疾病、疫苗相關之醫藥品的研究開發之獨立型生物醫藥品企業。

本報告提供Laboratorios LETI S.L.的治療藥開發平台現狀及各開發階段比較分析,為您彙整藥物標的,作用機制,給藥途徑,各分子類型的治療藥評估,最新的企業新聞和發表,後期階段及中止的計劃等相關資訊。

Laboratorios LETI S.L.的基本資料

Laboratorios LETI S.L.概要

  • 主要資訊
  • 企業資料

Laboratorios LETI S.L.:R&D概要

  • 主要的治療範圍

Laboratorios LETI S.L.:開發平台的檢討

  • 各開發階段的開發中產品
  • 單劑產品

Laboratorios LETI S.L.:開發中產品概況

  • 最後階段的開發中產品
    • 第三階段的產品/聯合治療模式

Laboratorios LETI S.L.:藥物簡介

  • Allergen Extract Of Phleum Pratense
  • Depigoid Birch
  • Olea Europaea Pollen Extract

Laboratorios LETI S.L.:開發平台分析

  • 各給藥途徑
  • 各分子類型

Laboratorios LETI S.L.:最近的開發平台趨勢

Laboratorios LETI S.L.:暫停中的計劃

Laboratorios LETI S.L.:企業發表

Laboratorios LETI S.L.:總公司和子公司的所地

Laboratorios LETI S.L.:主要製造設備

附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GMDHC06818CDB

Summary

Global Markets Direct's, 'Laboratorios LETI S.L. - Product Pipeline Review - 2015', provides an overview of the Laboratorios LETI S.L.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Laboratorios LETI S.L.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of Laboratorios LETI S.L. including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of Laboratorios LETI S.L.'s human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the Laboratorios LETI S.L.'s pipeline products

Reasons to buy

  • Evaluate Laboratorios LETI S.L.'s strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of Laboratorios LETI S.L. in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the Laboratorios LETI S.L.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of Laboratorios LETI S.L. and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of Laboratorios LETI S.L.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of Laboratorios LETI S.L. and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Laboratorios LETI S.L. Snapshot
    • Laboratorios LETI S.L. Overview
    • Key Information
    • Key Facts
  • Laboratorios LETI S.L. - Research and Development Overview
    • Key Therapeutic Areas
  • Laboratorios LETI S.L. - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
  • Laboratorios LETI S.L. - Pipeline Products Glance
    • Laboratorios LETI S.L. - Late Stage Pipeline Products
      • Phase III Products/Combination Treatment Modalities
    • Laboratorios LETI S.L. - Clinical Stage Pipeline Products
      • Phase II Products/Combination Treatment Modalities
  • Laboratorios LETI S.L. - Drug Profiles
    • Allergen Extract Of Phleum Pratense
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Depigoid Birch
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Olea Europaea Pollen Extract
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Cat Epithelial Allergenic Extract
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Dermatophagoides Pteronyssinus Allergen Extract
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • Laboratorios LETI S.L. - Pipeline Analysis
    • Laboratorios LETI S.L. - Pipeline Products by Route of Administration
    • Laboratorios LETI S.L. - Pipeline Products by Molecule Type
  • Laboratorios LETI S.L. - Recent Pipeline Updates
  • Laboratorios LETI S.L. - Dormant Projects
  • Laboratorios LETI S.L. - Company Statement
  • Laboratorios LETI S.L. - Locations And Subsidiaries
    • Head Office
    • Other Locations & Subsidiaries
  • Laboratorios LETI S.L. - Key Manufacturing Facilities
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Laboratorios LETI S.L., Key Information
  • Laboratorios LETI S.L., Key Facts
  • Laboratorios LETI S.L. - Pipeline by Indication, 2015
  • Laboratorios LETI S.L. - Pipeline by Stage of Development, 2015
  • Laboratorios LETI S.L. - Monotherapy Products in Pipeline, 2015
  • Laboratorios LETI S.L. - Phase III, 2015
  • Laboratorios LETI S.L. - Phase II, 2015
  • Laboratorios LETI S.L. - Pipeline by Route of Administration, 2015
  • Laboratorios LETI S.L. - Pipeline by Molecule Type, 2015
  • Laboratorios LETI S.L. - Recent Pipeline Updates, 2015
  • Laboratorios LETI S.L. - Dormant Developmental Projects,2015
  • Laboratorios LETI S.L., Subsidiaries
  • Laboratorios LETI S.L., Key Manufacturing Facilities

List of Figures

  • Laboratorios LETI S.L. - Pipeline by Top 10 Indication, 2015
  • Laboratorios LETI S.L. - Pipeline by Stage of Development, 2015
  • Laboratorios LETI S.L. - Monotherapy Products in Pipeline, 2015
  • Laboratorios LETI S.L. - Pipeline by Top 10 Route of Administration, 2015
  • Laboratorios LETI S.L. - Pipeline by Top 10 Molecule Type, 2015
Back to Top